Fidelity Growth Partners, the private equity arm of Fidelity Worldwide Investment, along with existing investors have invested $40.6 million in India’s Aptuit Laurus Pvt. Ltd., Aptuit Laurus is a manufacturer of active pharmaceutical ingredients for anti-retroviral, oncological and nutraceutical products.
Chava Satyanarayana, founder and CEO of Aptuit Laurus, also invested along with Fidelity, according to reports.
Aptuit Laurus is headquartered in Hyderabad.
Source: Indus Business